Skip to content

DNTH

Dianthus Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$101.00-4.36%

Price as of Jul 20, 2026

DNTH capital

Dianthus Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.00x
Net debt / equity
-0.52x
Debt / assets
0.00x
Debt / EBITDA
-0.13x
Net debt / EBITDA
57.66x

Liquidity & coverage

Current ratio
29.25x
Quick ratio
29.25x
Cash ratio
29.03x
Interest coverage
EBITDA / interest
Working capital
$1.1B

Cash & dividend

FCF / debt
-95.66x
Cash flow / debt
-95.52x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.